APEX1 and lung cancer: CPM can significantly inhibit cell viability, ROS production, intracellular pH, migration in hypoxic lung cancer cells, and angiogenesis of HUVECs under hypoxia through the inhibition of APEX1/HIF-1α interaction [56].